Evidence map›Paper›PMID 40204235›Full record

ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2026

Multiscale Heterogeneity of White Matter Morphometry in Psychiatric Disorders.

Ashlea Segal, Robert E Smith, Sidhant Chopra, Stuart Oldham, Linden Parkes, Kevin Aquino, Seyed Mostafa Kia, Thomas Wolfers, Barbara Franke, Martine Hoogman and 17 more

Abstract read
In one paragraph

Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Ashlea SegalTurner Institute for Brain and Mental Health, School of Psychological Science, Monash University, Melbourne, Victoria, Australia; Monash Biomedical Imaging, Monash University, Melbourne, Victoria, Australia; Department of Neuroscience, Wu Tsai Institute, Yale University, New Haven, Connecticut. Electronic address: Ashlea.segal@gmail.com.
Robert E SmithThe Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia; Florey Department of Neuroscience and Mental Health, Parkville, Victoria, Australia.
Sidhant ChopraDepartment of Psychology, Yale University, New Haven, Connecticut.
Stuart OldhamTurner Institute for Brain and Mental Health, School of Psychological Science, Monash University, Melbourne, Victoria, Australia; Monash Biomedical Imaging, Monash University, Melbourne, Victoria, Australia; Developmental Imaging, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Linden ParkesDepartment of Psychiatry, Rutgers University, Piscataway, New Jersey.
Kevin AquinoBrainKey Inc., Palo Alto, California.
Seyed Mostafa KiaDonders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands; Department of Psychiatry, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Cognitive Science and Artificial Intelligence, Tilburg School of Humanities and Digital Sciences, Tilburg University, Tilburg, the Netherlands.
Thomas WolfersDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands; Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo & Oslo University Hospital, Oslo, Norway; Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health, University of Tübingen, Tübingen, Germany.
Barbara FrankeDepartment of Cognitive Neuroscience, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Human Genetics, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Martine HoogmanDepartment of Human Genetics, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Psychiatry, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Christian F BeckmannDonders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands; Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, the Netherlands; Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, United Kingdom.
Lars T WestlyeNorwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, University of Oslo & Oslo University Hospital, Oslo, Norway; Department of Psychology, University of Oslo, Oslo, Norway; KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo and Oslo University Hospital, Oslo, Norway.
Ole A AndreassenDepartment of Psychology, University of Oslo, Oslo, Norway; KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo and Oslo University Hospital, Oslo, Norway.
Andrew ZaleskyMelbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia; Department of Biomedical Engineering, The University of Melbourne, Melbourne, Victoria, Australia.
Ben J HarrisonDepartment of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
Christopher G DaveyDepartment of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
Carles Soriano-MasDepartment of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Carlos III Health Institute, Madrid, Spain; Department of Social Psychology and Quantitative Psychology, Universitat de Barcelona-UB, Barcelona, Spain.
Narcís CardonerCentro de Investigación Biomédica en Red de Salud Mental, Carlos III Health Institute, Madrid, Spain; Sant Pau Mental Health Research Group, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Jeggan TiegoTurner Institute for Brain and Mental Health, School of Psychological Science, Monash University, Melbourne, Victoria, Australia; Monash Biomedical Imaging, Monash University, Melbourne, Victoria, Australia.
Murat YücelTurner Institute for Brain and Mental Health, School of Psychological Science, Monash University, Melbourne, Victoria, Australia; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Leah BraganzaTurner Institute for Brain and Mental Health, School of Psychological Science, Monash University, Melbourne, Victoria, Australia.
Chao SuoTurner Institute for Brain and Mental Health, School of Psychological Science, Monash University, Melbourne, Victoria, Australia; Monash Biomedical Imaging, Monash University, Melbourne, Victoria, Australia; Australian Characterisation Commons at Scale Project, Monash eResearch Centre, Melbourne, Victoria, Australia.
Michael BerkInstitute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia; Orygen, Melbourne, Victoria, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia; The Florey Institute for Neuroscience and Mental Health, Parkville, Victoria, Australia.
Sue CottonOrygen, Melbourne, Victoria, Australia; Centre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
Mark A BellgroveTurner Institute for Brain and Mental Health, School of Psychological Science, Monash University, Melbourne, Victoria, Australia.
Andre F MarquandDonders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, the Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands; Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Neuroimaging, Centre of Neuroimaging Sciences, Institute of Psychiatry, King's College London, London, United Kingdom.
Alex FornitoTurner Institute for Brain and Mental Health, School of Psychological Science, Monash University, Melbourne, Victoria, Australia; Monash Biomedical Imaging, Monash University, Melbourne, Victoria, Australia.

Funding

Discovering prognostic neuroimaging biomarkers of the psychosis spectrum using network control theoryR00MH127296 · NIMH · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI PARKES, LINDEN · 2023 to 2025
$747k
NIMH NIH HHS R00 MH127296Wellcome Trust
6 · The paper itself

Abstract

backgroundInterindividual variability in the neurobiological and clinical characteristics of mental illnesses are often overlooked by classical group-mean case-control studies. Studies using normative modeling to infer person-specific deviations of gray matter volume have indicated that group means are not representative of most individuals. The extent to which this variability is present in white matter morphometry, which is integral to brain function, remains unclear.

methodsWe applied warped Bayesian linear regression normative models to T1-weighted magnetic resonance imaging data and mapped interindividual variability in person-specific white matter volume (WMV) deviations in 1294 cases (58% male) diagnosed with one of 6 disorders (attention-deficit/hyperactivity disorder, autism, bipolar disorder, major depressive disorder, obsessive-compulsive disorder, and schizophrenia) and 1465 matched control participants (54% male) recruited across 25 scan sites. We developed a framework to characterize deviation heterogeneity on multiple spatial scales from individual voxels through interregional connections, specific brain regions, and spatially extended brain networks.

resultsThe specific locations of WMV deviations were highly heterogeneous across participants, affecting the same voxel in fewer than 8% of individuals with the same diagnosis. For autism and schizophrenia, negative deviations (i.e., areas where volume is lower than normative expectations) aggregated into common tracts, regions, and large-scale networks in up to 69% of individuals.

conclusionsThe prevalence of WMV deviations was lower than previously observed in gray matter, and the specific location of these deviations was highly heterogeneous when considering voxelwise spatial resolution. Evidence of aggregation within common pathways and networks was apparent in schizophrenia and autism but not in other disorders.

Indexed as

BrainMental DisordersWhite MatterAdultBayes TheoremCase-Control StudiesFemaleHumansMagnetic Resonance ImagingMaleYoung AdultConnectomeHeterogeneityMRINormative modelingPsychiatric disordersWhite matter volume

Identifiers

PMID40204235
PMCPMC12441912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.